Ignite Creation Date:
2024-05-06 @ 12:17 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01530334
Status:
COMPLETED
Last Update Posted:
2016-02-23
First Post:
2012-01-31
Brief Title:
Iressa Re-Challenge in Advanced NSCLC EGFR M Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-31
First Submit QC Date:
February 7 2012
Study First Post Date:
2012-02-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-02-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-26
Last Update Post Date:
2016-02-23
Last Update Post Date Type:
ESTIMATED